To Evaluate the Efficacy of Toripalimab Combined With Chemotherapy After HIFU Induction in the Treatment of Early Triple-negative Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|TNBC - Triple-Negative Breast Cancer
Interventions: DRUG: Toripalimab|DRUG: Epirubicin|PROCEDURE: High Intensity Focused Ultrasoun|DRUG: Cyclophosphamide|DRUG: Carboplatin|DRUG: Nab-paclitaxel
Sponsor: The First Affiliated Hospital with Nanjing Medical University